Skip to Main Content

Paper Details

Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced <i>KRAS G12C</i>-Mutant Non-Small Cell Lung Cancer.
JCO Precis Oncol
10
2023
Advanced -Mutant Non-Small Cell Lung Cancer, G12C, KRAS, KRAS G12C, NSCLC, Patients, Sotorasib, TRAE, advanced, advanced -mutant non-small cell lung cancer, anti-PD-, anti-PD-(L)1, hepatotoxicity, patients, sotorasib
Author NameAffiliation
Marc LadanyiMemorial Sloan Kettering Cancer Center
Ronglai ShenMemorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2